Lab Notes: NRx seeks patent for Covid-19 therapy; Baudax Bio raises $4.2M
January 07, 2022 at 12:29 PM EST
Philadelphia-area life sciences news this week includes updates on a company seeking a patent for its Covid-19 therapy, a private stock sale, and a Temple University spinout publishing its study findings on a potential treatment for NASH.
